Jürgen C Becker

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.

Mads Hald Andersen, Julie Gehl, J. Becker, 2003, Seminars in cancer biology.

Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

J. Becker, M. Buttmann, C. Beier, 2009, Cancer research.

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes

Morten Nielsen, Paolo Marcatili, Sine R Hadrup, 2018, Nature Biotechnology.

Cytotoxic T cells.

Mads Hald Andersen, David Schrama, J. Becker, 2006, The Journal of investigative dermatology.